In the course of screening microorganisms for the ability to modify known antitumor agents, we identified a strain of Whetzelinia sclerotiorum which transformed several compounds related to aureolic acid1).
As substrates we used compounds isolated in our laboratories: NSC-A6492), an antibiotic which was subsequently characterized and named olivomycin by Russian workers3,4) and NSC-135052, (D. E. NETTLETON, unpublished results) which we identified as a mixture of chromomycins A2 and A235).
The structures of these compounds had been elucidated by Russian3,4) and Japanese5) investigators.
The transformed substances were isolated from complex mixtures by methods similar to those em- 
